Overview Financials News + Filings Key Docs Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
BioNexus Gene Lab Corp
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/11/2023 |
8-K
| Quarterly results |
| 10/04/2023 |
3
| Wong Yee Meng (President) has filed a Form 3 on BioNexus Gene Lab Corp |
| 10/04/2023 |
3
| Yap Chee Keong (Director) has filed a Form 3 on BioNexus Gene Lab Corp |
| 10/04/2023 |
3
| Yew Chak Hua (Director) has filed a Form 3 on BioNexus Gene Lab Corp |
| 10/04/2023 |
3
| Lin Chai Ping (Director) has filed a Form 3 on BioNexus Gene Lab Corp |
| 10/04/2023 |
3
| Teoh Boon Teong (Director) has filed a Form 3 on BioNexus Gene Lab Corp |
| 10/04/2023 |
3
| Fong Yeat Min (Director) has filed a Form 3 on BioNexus Gene Lab Corp |
| 10/04/2023 |
3
| Yeoh Sook Keng (CEO) has filed a Form 3 on BioNexus Gene Lab Corp |
| 10/04/2023 |
3
| Leong Wei Li (CFO) has filed a Form 3 on BioNexus Gene Lab Corp |
| 10/04/2023 |
3
| Liong Tai Tan (COO) has filed a Form 3 on BioNexus Gene Lab Corp |
| 10/04/2023 |
3
| Fong Teng Fook (Director) has filed a Form 3 on BioNexus Gene Lab Corp |
| 08/16/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/14/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 07/24/2023 |
8-K
| Quarterly results |
| 07/21/2023 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 07/20/2023 |
CERT
| Form CERT - Certification by an exchange approving securities for listing: |
| 07/20/2023 |
8-K
| Quarterly results |
| 07/20/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/19/2023 |
8-A12B
| Form 8-A12B - Registration of securities [Section 12(b)]: |
| 07/14/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 07/03/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 05/17/2023 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/10/2023 |
DEFR14C
| Form DEFR14C - Revised information statement materials, definitive: |
| 02/14/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 02/10/2023 |
PRE 14C
| Form PRE 14C - Other preliminary information statements: |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/15/2022 |
8-K
| Quarterly results |
| 05/16/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 04/06/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 04/01/2022 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 11/15/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
|
|
|